Interferon treatment for multiple sclerosis: Autoimmune complications may be lethal

被引:34
作者
Durelli, L
Bongioanni, MR
Ferrero, B
Oggero, A
Marzano, A
Rizzetto, M
机构
[1] Univ Turin, Dipartimento Neurosci, Turin, Italy
[2] Univ Turin, Neurol Clin 1, Turin, Italy
[3] Osped Maggiore San Giovanni Battista, Div Gastroenterol, Turin, Italy
关键词
D O I
10.1212/WNL.50.2.570
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:570 / 571
页数:2
相关论文
共 7 条
[1]  
DUQUETTE P, 1995, NEUROLOGY, V45, P1277
[2]   CHRONIC SYSTEMIC HIGH-DOSE RECOMBINANT INTERFERON ALFA-2A REDUCES EXACERBATION RATE, MRI SIGNS OF DISEASE-ACTIVITY, AND LYMPHOCYTE INTERFERON-GAMMA PRODUCTION IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS [J].
DURELLI, L ;
BONGIOANNI, MR ;
CAVALLO, R ;
FERRERO, B ;
FERRI, R ;
FERRIO, MF ;
BRADAC, GB ;
RIVA, A ;
VAI, S ;
GEUNA, M ;
BERGAMINI, L ;
BERGAMASCO, B .
NEUROLOGY, 1994, 44 (03) :406-413
[3]  
Durelli Luca, 1997, Neurology, V48, pA245
[4]   FATAL HEPATIC DECOMPENSATION ASSOCIATED WITH INTERFERON ALFA [J].
JANSSEN, HLA ;
BROUWER, JT ;
NEVENS, F ;
SANCHEZTAPIAS, JM ;
CRAXI, A ;
HADZIYANNIS, S .
BRITISH MEDICAL JOURNAL, 1993, 306 (6870) :107-108
[5]   Medical progress - Autoimmune hepatitis [J].
Krawitt, EL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (14) :897-903
[6]   CLINICAL TOXICITY OF THE INTERFERONS [J].
VIAL, T ;
DESCOTES, J .
DRUG SAFETY, 1994, 10 (02) :115-150
[7]   IMMUNOLOGICAL ADVERSE-EFFECTS OF INTERFERON TREATMENT [J].
YOSHIKAWA, M ;
FUKUI, H ;
TSUJII, T .
CLINICAL IMMUNOTHERAPEUTICS, 1995, 4 (05) :361-375